Sales drive up CogState revenues
Wednesday, 24 August, 2005
Melbourne-based neurodiagnostic specialist CogState (ASX:CGS) has reported revenues of AUD$1.5 million for the financial year ending June 30 2005, nearly three times more than the previous corresponding period, largely through sales to major pharmaceutical companies and research institutions.
The company recorded an increase in sales of its diagnostic product of 434 per cent, up from $192,094 in 2004 to $1 million in 2005.
Cogstate reported a net loss of $2.2 million and at 30 June 2005 had a cash balance of balance of $3.4 million.
Immune cell boost could enable lasting vaccine protection
A research team has found a promising new way to enhance the effectiveness of vaccines by tapping...
Genes influence when babies start walking
Genetics accounts for about a quarter of the differences in when children take their first steps,...
Novel glycopeptide antibiotic candidate shows promise
Researchers have discovered a new type of glycopeptide antibiotic known as saarvienin A, found to...
